299 related articles for article (PubMed ID: 23661264)
21. [Pre- and postoperative chemotherapy in bone and soft tissue tumors].
Höffken K
Langenbecks Arch Chir; 1987; 372():311-4. PubMed ID: 3481009
[TBL] [Abstract][Full Text] [Related]
22. Novel treatment targets in sarcoma: more than just the GIST.
Shoushtari AN; Van Tine BA; Schwartz GK
Am Soc Clin Oncol Educ Book; 2014; ():e488-95. PubMed ID: 24857144
[TBL] [Abstract][Full Text] [Related]
23. Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas.
Casali PG
Ann Oncol; 2012 Sep; 23 Suppl 10():x167-9. PubMed ID: 22987955
[TBL] [Abstract][Full Text] [Related]
24. Sarcoma chemotherapy.
Walczak BE; Irwin RB
J Am Acad Orthop Surg; 2013 Aug; 21(8):480-91. PubMed ID: 23908254
[TBL] [Abstract][Full Text] [Related]
25. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
Aragon-Ching JB; Maki RG
Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
[TBL] [Abstract][Full Text] [Related]
26. New therapeutic targets in soft tissue sarcoma.
Demicco EG; Maki RG; Lev DC; Lazar AJ
Adv Anat Pathol; 2012 May; 19(3):170-80. PubMed ID: 22498582
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy of advanced sarcomas of bone and soft tissue.
Antman KH
Semin Oncol; 1992 Dec; 19(6 Suppl 12):13-20. PubMed ID: 1485169
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tsuchiya H
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621224
[TBL] [Abstract][Full Text] [Related]
29. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
Riedel RF
Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
[TBL] [Abstract][Full Text] [Related]
30. Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself.
Yang QK; Chen T; Wang SQ; Zhang XJ; Yao ZX
Angiogenesis; 2020 Aug; 23(3):279-298. PubMed ID: 32333216
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets.
Merlini A; Rabino M; Brusco S; Pavese V; Masci D; Sangiolo D; Bironzo P; Scagliotti GV; Novello S; D'Ambrosio L
Expert Opin Ther Targets; 2024; 28(1-2):17-28. PubMed ID: 38234142
[TBL] [Abstract][Full Text] [Related]
32. Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy.
Patel SR
Am Soc Clin Oncol Educ Book; 2014; ():259-62. PubMed ID: 24857084
[TBL] [Abstract][Full Text] [Related]
33. Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.
Mita MM; Gong J; Chawla SP
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):465-82. PubMed ID: 23971829
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary evaluation of the effectiveness of holoxan in the treatment of malignant soft tissue and bone neoplasms].
Utracka-Hutka B; Czownicki Z
Nowotwory; 1981; 31(2):147-53. PubMed ID: 7038629
[No Abstract] [Full Text] [Related]
35. Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of Cancer.
Bramwell VH; Santoro A; Rouesse J; Mouridsen H; Steward W; Van Oosterom A; Somers R; Buesa J; Mulder J; Schutte J
Semin Surg Oncol; 1988; 4(1):45-52. PubMed ID: 3281211
[TBL] [Abstract][Full Text] [Related]
36. [Targeted treatment of rare connective tissue tumors and sarcomas].
Cassier P; Pissaloux D; Alberti L; Ray-Coquard I; Blay JY
Bull Cancer; 2010 Jun; 97(6):693-700. PubMed ID: 20497911
[TBL] [Abstract][Full Text] [Related]
37. Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.
Saiki JH; Baker LH; Stephens RL; Fabian CJ; Kraut EH; Fletcher WS
Cancer Treat Rep; 1982 Aug; 66(8):1673-4. PubMed ID: 7105060
[No Abstract] [Full Text] [Related]
38. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Tawbi HA; Burgess M; Bolejack V; Van Tine BA; Schuetze SM; Hu J; D'Angelo S; Attia S; Riedel RF; Priebat DA; Movva S; Davis LE; Okuno SH; Reed DR; Crowley J; Butterfield LH; Salazar R; Rodriguez-Canales J; Lazar AJ; Wistuba II; Baker LH; Maki RG; Reinke D; Patel S
Lancet Oncol; 2017 Nov; 18(11):1493-1501. PubMed ID: 28988646
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
Todd R; Lunec J
Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
[TBL] [Abstract][Full Text] [Related]
40. Role of chemotherapy in pediatric nonrhabdomyosarcoma soft-tissue sarcomas.
Ferrari A
Expert Rev Anticancer Ther; 2008 Jun; 8(6):929-38. PubMed ID: 18533802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
